A 72-year-old woman with a history of myocardial infarction 2 weeks ago presents with sudden onset of severe left lower limb pain and coolness. Clinical examination reveals absent femoral pulse, mottled skin, and sensory loss in the foot. The limb appears cyanotic. Which investigation should be performed immediately to assess the extent of tissue damage and guide the decision between revascularization and amputation?

Explanation

## Assessment of Tissue Damage in Acute Limb Ischemia **Key Point:** In acute limb ischemia with signs of irreversible ischemia (mottling, sensory loss, cyanosis), **serum lactate and creatine kinase (CK) levels** are the immediate investigations of choice to quantify the extent of muscle necrosis and systemic metabolic compromise, guiding the revascularization vs. amputation decision. ### Why Serum Lactate and CK? 1. **Immediate Availability** - Results available within minutes at the bedside or in the emergency lab - No delay for imaging suite availability or contrast administration - Critical in a time-sensitive emergency where every minute of ischemia worsens prognosis 2. **Markers of Muscle Necrosis and Systemic Ischemia** - **Creatine Kinase (CK):** Rises sharply with myonecrosis; markedly elevated CK (>10,000 IU/L) indicates extensive irreversible muscle damage and predicts post-reperfusion complications (myoglobinuria, renal failure) - **Serum Lactate:** Reflects global tissue hypoperfusion and anaerobic metabolism; elevated lactate (>2 mmol/L) confirms significant ischemic burden and guides urgency of intervention 3. **Guides Revascularization vs. Amputation** - Profoundly elevated CK + lactate in the context of Rutherford Grade IIb–III ischemia signals that revascularization may precipitate life-threatening reperfusion injury (hyperkalemia, myoglobinuric renal failure, cardiac arrest) - Supports primary amputation as the safer option in irreversible ischemia **Clinical Pearl:** Per Rutherford classification, this patient's findings (absent pulse, mottled skin, sensory loss, cyanosis) suggest Grade IIb–III ischemia. In this setting, the **immediate** investigation is biochemical (lactate + CK), not imaging. CTA angiography, while valuable for vascular mapping, introduces unacceptable delay and does not directly quantify muscle viability as rapidly as serum biomarkers. **High-Yield:** Serum CK and lactate are the bedside investigations that most directly answer "how much muscle is dead?" — the core question when deciding between revascularization and amputation in advanced acute limb ischemia. (Reference: Rutherford's Vascular Surgery, 8th ed.; ESC Guidelines on Peripheral Arterial Diseases 2017) ### Why the Other Options Are Incorrect | Option | Reason Incorrect | |--------|-----------------| | Plain radiography | Shows bone only; no soft tissue or vascular information | | CT angiography | Valuable for vascular mapping but NOT the immediate first step; delays treatment and does not directly quantify myonecrosis | | TcPO₂ | Useful for chronic limb ischemia wound healing prediction; not validated or practical for acute ischemia triage | **Mnemonic:** **LACK** — **L**actate **A**nd **C**K are the **K**ey immediate tests in acute limb ischemia to assess tissue viability.